Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

XenoSure Dura Biologic Patch

K-Number: K183513 · 2019-06-13

Decision Date2019-06-13
Product CodeGXQ
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

XenoSure Dura Biologic Patch is a medical device manufactured by LeMaitre Vascular, Inc.. It received FDA 510(k) clearance on 2019-06-13 under approval number K183513. The device is classified under product code GXQ. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the XenoSure Dura Biologic Patch?

XenoSure Dura Biologic Patch is a medical device that received FDA 510(k) clearance on 2019-06-13. It is manufactured by LeMaitre Vascular, Inc.. The 510(k) number is K183513.

When was XenoSure Dura Biologic Patch approved by the FDA?

XenoSure Dura Biologic Patch received FDA 510(k) clearance on 2019-06-13, under approval number K183513.

What company makes XenoSure Dura Biologic Patch?

XenoSure Dura Biologic Patch is manufactured by LeMaitre Vascular, Inc..

What is the FDA product code for XenoSure Dura Biologic Patch?

The FDA product code for XenoSure Dura Biologic Patch is GXQ.

Other Devices by LeMaitre Vascular, Inc.

Related Devices (Code: GXQ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.